Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2010 Financial Results
Date:11/4/2010

NEW YORK, Nov. 4, 2010 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease (the "Company"), today announced its results for the third quarter ended September 30, 2010.

At September 30, 2010, the Company had cash, cash equivalents, interest receivable and investment securities of $34.4 million, as compared to $31.7 million at June 30, 2010, and $35.9 million at December 31, 2009.  During the third quarter, the Company received approximately $5.7 million in net proceeds from the exercise of the remaining warrants from the Company's September 2009 registered direct offering.

The net loss for the third quarter ended September 30, 2010 was $5.8 million, or $0.10 per diluted share, compared to net income of $0.6 million, or $0.01 per diluted share, for the third quarter in 2009, representing a change in net (loss) income of $6.4 million.  The three months ended September 30, 2009 included $3.5 million in other revenue, related to the settlement of a dispute with the former licensor of Sulonex (sulodexide), in July 2009, over issues arising from the terminated license agreement.  The three months ended September 30, 2010 included a $2.2 million increase in research and development expenses related to KRX-0401 (perifosine) and Zerenex as compared to the comparable period last year, primarily related to the Company's ongoing Phase 3 clinical development programs.  The net loss for the third quarter ended September 30, 2010, included $0.6 million of non-cash compensation expense related to equity incentive grants.

The net loss for the nine months ended September 30, 2010 was $15.0 million, or $0.26 per diluted share
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
2. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
3. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
4. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
5. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
6. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
7. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
8. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
9. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
10. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
11. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014  The National Association of Drug ... achieved by the real-time, pseudoephedrine (PSE) blocking system ... Log Exchange (NPLEx), automatically blocks unlawful PSE sales ... offenders and make arrests. Data released by NPLEx ... blocked the sale of more than 32,105 ...
(Date:8/20/2014)... , Aug. 20, 2014  The National Association ... latest results achieved by the real-time, pseudoephedrine (PSE) ... National Precursor Log Exchange (NPLEx), automatically blocks unlawful ... down methamphetamine offenders and make arrests. Data released ... Missouri blocked the sale of more ...
(Date:8/20/2014)... Aug. 20, 2014 Reportlinker.com ... report is available in its catalogue: ... Infection Control (Sterilization, Disinfection, Testing and ... Given the cost ... demand has increased for solutions that ...
Breaking Medicine Technology:Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Missouri's Stop-Sale System Achieves Significant Results In Battle Against Meth 2The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 2The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 3The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 4The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 5The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 6
... Cetrorelix showed good safety and tolerability profile ... level,Japanese partner Shionogi initiates Phase 2b trial, ... AEterna,Zentaris Inc. along with its Japanese partner ... for a Phase 2a trial with,cetrorelix in ...
... WIRE)--Mar 22, 2007 - Nutra Pharma,Corp. (OTCBB: ... for HIV and Multiple Sclerosis has today ... received notification of,acceptance of its paper for ... conference issue., The article, entitled "Alpha-Cobratoxin as ...
Cached Medicine Technology:AEterna Zentaris Reports Positive Results with Cetrorelix in BPH,for Japanese Phase 2a Trial 2AEterna Zentaris Reports Positive Results with Cetrorelix in BPH,for Japanese Phase 2a Trial 3AEterna Zentaris Reports Positive Results with Cetrorelix in BPH,for Japanese Phase 2a Trial 4Nutra Pharma Announces Publication of Research on Treatment for,Multiple Sclerosis 2Nutra Pharma Announces Publication of Research on Treatment for,Multiple Sclerosis 3
(Date:8/21/2014)... August 21, 2014 Hunhu Healthcare, ... solutions, announced today that it has entered into a ... practices, mobile technology and predictive analytics for recruiting, leveraging ... , According to Michael Emerson , co-founder and ... two patents on the technology used in what he ...
(Date:8/21/2014)... DMG Productions announces the upcoming airing of ... Monday, August 25, 2014 at 7:00 a.m. EST and ... this episode, Innovations will go behind-the-scenes to demonstrate how ... performance. Audiences will be amazed by the park's that ... and providing access to real musical instruments. , Audiences ...
(Date:8/21/2014)... Poorly-made dental restorations – whether produced in America ... health consequences for patients. To ensure better outcomes for ... and patients have a full understanding of where their ... used in the process. , Some patients believe their ... not even think twice about where their restorations are ...
(Date:8/21/2014)... Studies find that participating in a juice ... clearer skin, more energy, refresh the taste buds, help lose ... wellness center in Beverly Hills, is excited to offer guests ... their recovery room. , β€œIt’s important that we offer patients ... surgery in our Los Angeles recovery room ,” says ...
(Date:8/21/2014)... HIPAA Secure Now! rolled out its EHR (electronic ... vendors to now offer their customers a HIPAA security ... , HIPAA Secure Now! provides risk analysis services, ... U.S. The company assesses the risks of storing and ... and device used by the practice. , HIPAA ...
Breaking Medicine News(10 mins):Health News:Hunhu Healthcare Enters into Licensing Agreement with Mayo Clinic 2Health News:Announcing New Episode Airing of Innovations on Monday August 25, 2014 via Discovery Channel 2Health News:4 Questions to Ask Before Your Next Dentist Appointment 2Health News:4 Questions to Ask Before Your Next Dentist Appointment 3Health News:Los Angeles Surgery Recovery Center Now Offering Juice Cleanses 2Health News:Los Angeles Surgery Recovery Center Now Offering Juice Cleanses 3Health News:HIPAA Secure Now! Ramps up EHR Partner Program, Helps Healthcare Providers Achieve Meaningful Use under Revised CMS Deadlines 2
... April 27 minor surgery reveals inoperable pancreatic and spinal ... Hennie Page had finally settled into a quiet life ... enjoys looking at his,paintings and frequent visits from his ... the world in years past -- leading,chartered cruises in ...
... 3 Market competition is,mounting to win the ... investigators. Field research shows that the most sought-after,clinical ... trial,invitations that they receive at their labs and ... to manage the art,and science of investigator recruitment., ...
... Grills, Photo Books and Shaving Kits Are Just a ... CVS/pharmacy,s 6,300 Convenient U.S. Locations, WOONSOCKET, R.I., June ... locations nationwide, offers,shoppers a wide selection of affordable, department ... just the right gift., "Consumers are scaling back ...
... . , Images of the inside of the intestine can ... no larger than a candy. It makes its way through the ... receiver which the patient carries on a belt. This device stores ... identify any hemorrhages or cysts. However, the camera is not very ...
... Flashpoint Medica, a full-service,healthcare advertising agency and member ... launched Flashlight Interactive, a new business unit devoted ... by agency veteran Kristen,Goelz, who joins the company ... Interactive will offer a variety of programs and,capabilities, ...
... study at the Montreal Neurological Institute at McGill University ... motor nerve cells (motor neurons) - cells that control ... a range of conditions involving nerve cell loss or ... as ALS, also known as Lou Gehrig,s disease. , ...
Cached Medicine News:Health News:Sherwood, Oregon Sailor, 78, Goes on Final Voyage 2Health News:Best Practice Toolkit Supports Recruitment of Top Clinical Investigators 2Health News:Practical Gear and Personal Gadgets: CVS/pharmacy Offers a Wide Selection of Affordable Gifts to Delight Dad This Father's Day 2Health News:Practical Gear and Personal Gadgets: CVS/pharmacy Offers a Wide Selection of Affordable Gifts to Delight Dad This Father's Day 3Health News:Magnet-controlled camera in the body 2Health News:Flashpoint Launches Flashlight Interactive, Names Kristen Goelz Head of New Division 2Health News:Finding clues for nerve cell repair 2
Inquire...
... design makes positioning quick and ... wheelchair accessible and can support ... lbs. The AIT-8B provides stable ... units and includes a motorized ...
If youre looking to expand your projection capabilities, without a major capital investment, consider Topcons CP-5D Chart Projector....
... FDA-Approved BV-1000 is the worlds ... system. With the BV-1000, Topcon ... of refracting instruments. This innovative ... binocular auto-refractor, auto-keratometer, automatic chart ...
Medicine Products: